What Are Ozempic Injections Used For?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections belong to a class of medications called GLP-1 receptor agonists, which mimic a natural hormone that regulates appetite and blood sugar control. Originally approved by the FDA in 2017 for type 2 diabetes management, semaglutide injections have become widely recognized for their ability to support weight management when combined with lifestyle modifications. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, making this therapy accessible across all 50 states without insurance requirements.

How Semaglutide Injections Work for Blood Sugar Control

Semaglutide injections function by activating GLP-1 receptors throughout the body, triggering a cascade of metabolic responses. When you inject semaglutide, it signals your pancreas to release insulin only when blood glucose levels rise, helping prevent dangerous spikes. This mechanism also slows gastric emptying—the rate at which food moves from your stomach—allowing your body more time to absorb nutrients and register fullness signals.

For individuals with type 2 diabetes, this dual action addresses two core problems: insufficient insulin production and insulin resistance at the cellular level. Clinical trials demonstrate that semaglutide injections can lower hemoglobin A1C (a three-month average of blood sugar) by 1.5 to 2 percentage points when combined with diet and exercise. The medication maintains this effect consistently over years of treatment, making it a reliable tool for long-term glycemic management.

Semaglutide Injections and Weight Management Goals

Weight reduction with semaglutide injections occurs through multiple biological pathways rather than simple appetite suppression. The medication increases satiety signals sent to your brain, meaning smaller portions feel satisfying and hunger between meals diminishes naturally. Additionally, semaglutide may increase energy expenditure slightly and reduce cravings for high-calorie foods by influencing reward centers in the brain that drive overeating.

Research published in major medical journals shows that patients using semaglutide injections achieve an average weight loss of 10 to 15 percent of their starting body weight over one year when paired with structured eating and movement plans. Results vary based on individual genetics, baseline metabolism, and adherence to lifestyle changes. PlexusDx offers the optional Precision Peptide Genetic Test to identify your genetic predispositions across 14 metabolic pathways, helping personalize your approach beyond one-size-fits-all dosing.

Primary Uses and Clinical Indications

Semaglutide injections carry FDA approval for two primary indications: improving glycemic control in adults with type 2 diabetes and supporting chronic weight management in adults with obesity or overweight status plus weight-related medical conditions. Healthcare providers may prescribe semaglutide injections off-label for prediabetes management, though this remains an emerging area of clinical practice. The medication is not indicated for type 1 diabetes or as a replacement for insulin in type 2 patients requiring intensive insulin therapy.

Beyond glucose and weight, semaglutide injections demonstrate cardiovascular benefits in high-risk populations. Studies reveal reductions in heart attack, stroke, and cardiovascular death among patients with established heart disease who use GLP-1 receptor agonists. These benefits extend beyond weight loss itself, suggesting semaglutide provides direct protective effects on blood vessel function and heart tissue.

Starting Semaglutide Injections with PlexusDx

PlexusDx delivers compounded semaglutide injections manufactured by licensed 503A pharmacies, ensuring pharmaceutical-grade quality without insurance requirements or membership fees. Treatment is $189/mo month-to-month, or from $149/mo on the 6-month plan across all commitment tiers—your dose may need to go up as your body adjusts, but your price will not. All medications arrive pre-filled or in convenient vial format with detailed injection instructions, and PlexusDx serves every state, accepting HSA and FSA funds for eligible accounts.

The typical starting dose is 0.25 mg weekly, gradually increasing over four to twelve weeks based on tolerance and response. Your PlexusDx provider evaluates your medical history, current medications, and any contraindications before prescribing. Optional add-on genetic testing through the Precision Peptide Genetic Test ($298) identifies how your unique genetic variants in GIPR and FTO, and MC4R pathways may influence your medication response and optimal nutrition strategy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between Ozempic and semaglutide injections from PlexusDx?

Ozempic is a branded semaglutide injection manufactured by Novo Nordisk and typically costs hundreds of dollars monthly with insurance. PlexusDx compounded semaglutide injections contain the same active pharmaceutical ingredient (semaglutide) sourced from licensed 503A compounding pharmacies and are $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance requirements, making the therapy more accessible for most patients.

Can semaglutide injections be used without diabetes?

Yes, semaglutide injections are FDA-approved for weight management in adults with obesity (BMI ≥30) or overweight status (BMI ≥27) plus weight-related medical conditions such as high blood pressure, elevated cholesterol, or sleep apnea. Many patients without diabetes use semaglutide injections safely to achieve health goals when combined with diet and lifestyle changes.

How much does semaglutide injection treatment cost with PlexusDx?

PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all three commitment tiers with flat pricing — your dose may go up, but your price won't. No insurance is required, and treatment is available in all 50 states. HSA and FSA funds cover the cost, and the optional Precision Peptide Genetic Test ($298) helps personalize your therapy.

What side effects should I expect from semaglutide injections?

Common side effects include nausea, vomiting, diarrhea, and constipation, especially during the first few weeks as your body adjusts. Most side effects decrease with continued use and dose stabilization. Serious but rare complications include pancreatitis and gallbladder issues; your PlexusDx provider screens for risk factors before prescribing and monitors you throughout treatment.

How does PlexusDx genetic testing help optimize my semaglutide response?

The Precision Peptide Genetic Test analyzes your variants in GIPR and FTO, and MC4R genes across 14 metabolic pathways, identifying genetic predispositions that influence how your body responds to semaglutide and which complementary lifestyle strategies work best for your unique biology. This personalized insight allows your PlexusDx provider to tailor nutrition guidance and dosing strategy beyond standard protocols.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.